Reed Joshua's most recent trade in Alkermes plc was a trade of 158,743 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alkermes PLC | Joshua Reed | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2025 | 158,743 | 158,743 | - | - | Employee Stock Option (Right to Buy) | |
| Alkermes PLC | Joshua Reed | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2025 | 36,656 | 36,656 | - | - | Restricted Stock Unit Award | |
| Scholar Rock Holding Corp | Joshua Reed | Director | Sale of securities on an exchange or to another person at price $ 29.68 per share. | 29 May 2025 | 4,900 | 16,232 (0%) | 0% | 29.7 | 145,441 | Common Stock |
| Scholar Rock Holding Corp | Joshua Reed | Director | Sale of securities on an exchange or to another person at price $ 30.04 per share. | 29 May 2025 | 500 | 15,732 (0%) | 0% | 30.0 | 15,022 | Common Stock |
| Scholar Rock Holding Corp | Joshua Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 9,206 | 9,206 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Joshua Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 7,632 | 21,132 (0%) | 0% | 0 | Common Stock | |
| Scholar Rock Holding Corp | Joshua Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Joshua Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 13,500 | 13,500 (0%) | 0% | 0 | Common Stock | |
| Omega Therapeutics Inc | Reed Joshua | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Joshua Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Omega Therapeutics Inc | Joshua Reed | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 55,000 | 55,000 | - | - | Option (Right to Buy) | |
| Omega Therapeutics Inc | Joshua Reed | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 320,000 | 320,000 | - | - | Option (Right to Buy) | |
| Scholar Rock Holding Corp | Joshua Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Aldeyra Therapeutics Inc | Joshua Reed | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 150,185 | 150,185 | - | - | Employee Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Joshua Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 15,600 | 15,600 | - | - | Stock Options (Right to Buy) |